301507.SHE Hangzhou Minsheng Healthcare Co Ltd
- Market cap
- CNY 4.20B
- P/E
- 47.2x
- P/B
- 2.49x
- ROE
- 6.9%
- Dividend yield
- 0.85%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301507.SHE undervalued?
Graham number301507.SHE trades 128.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hangzhou Minsheng Healthcare Co Ltd fundamental analysis
No fundamental analysis for Hangzhou Minsheng Healthcare Co Ltd yet.
Hangzhou Minsheng Healthcare Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hangzhou Minsheng Healthcare Co Ltd
Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and healthy foods in China and internationally. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin, vitamin, and zinc selenium with mineral tablets; and gluco…
Full company profileHangzhou Minsheng Healthcare Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hangzhou Minsheng Healthcare Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 490M | 547M | 582M | 641M | 782M | 992M |
| Gross Profit | 322M | 331M | 361M | 358M | 399M | 542M |
| Operating Income | 68.4M | 84.3M | 89.8M | 84.4M | 91.9M | 137M |
| EBITDA | - | 121M | 125M | 130M | 167M | 137M |
| Net Income | 70.2M | 79.0M | 85.6M | 91.8M | 119M | 112M |
| EPS | 0.26 | 0.30 | 0.24 | 0.26 | 0.33 | 0.32 |
| Balance Sheet | ||||||
| Total Assets | 681M | 765M | 1.65B | 1.74B | 2.02B | 2.09B |
| Total Liabilities | 166M | 171M | 175M | 214M | 299M | 353M |
| Shareholders' Equity | 515M | 594M | 1.47B | 1.53B | 1.60B | 1.62B |
| Cash & Short-term Investments | 22.3M | 47.3M | 428M | 339M | 289M | 215M |
| Cash Flow | ||||||
| Operating Cash Flow | 44.3M | 95.3M | 108M | 108M | 177M | - |
| Capital Expenditure | 25.6M | 26.9M | 36.1M | 94.9M | 196M | 150M |
| Free Cash Flow | 18.8M | 68.4M | 72.1M | 13.6M | -19.2M | 107M |
| Ratios | ||||||
| ROE | 13.6% | 13.3% | 5.8% | 6.0% | 7.4% | 6.9% |
| ROA | 10.3% | 10.3% | 5.2% | 5.3% | 5.9% | 5.4% |
| Net Profit Margin | 14.3% | 14.4% | 14.7% | 14.3% | 15.2% | 11.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Hangzhou Minsheng Healthcare Co Ltd dividends
- Dividend yield
- 0.85%
- Forward dividend
- 0.15 CNY
- Payout ratio
- 29.9%
- Ex-dividend date
- Jun 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 35.5M | 0.10 | 29.9% |
| 2024 | CNY 35.7M | 0.10 | 38.8% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | CNY 150M | 0.56 | 214.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Hangzhou Minsheng Healthcare Co Ltd
- Insiders 71.57%
- Institutions 0.95%
- Public & others 27.48%
- Shares outstanding 357M
- Free float 100M
Hangzhou Minsheng Healthcare Co Ltd company profile
- Company name
- Hangzhou Minsheng Healthcare Co Ltd
- Ticker
- 301507.SHE
- ISIN
- CNE1000068Q3
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 710
- Fiscal year end
- December
- Address
- No. 658, Bin'an Road, Hangzhou, China, 310051
- Phone
- 86 571888 07066
- Website
- hzmsjk.com
About Hangzhou Minsheng Healthcare Co Ltd
Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and healthy foods in China and internationally. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin, vitamin, and zinc selenium with mineral tablets; and glucosamine chondroitin colostrum protein chewable, vitamin soft capsules and chewable, iron folic acid, melatonin, coenzyme soft capsules, and calcium magnesium vitamin D tablets. The company offers its products under the 21 SUPER-VITA brand name. Hangzhou Minsheng Healthcare Co., Ltd. was founded in 1926 and is based in Hangzhou, China.
Hangzhou Minsheng Healthcare Co Ltd management
6- Mr. Haijun ZhangGM & Non-Independent Director · born 1981
- Mr. Wenjun ZhuFinancial Manager · born 1988
- Ms. Liyun LiuDeputy General Manager · born 1978
- Mr. Wenzhu ChenBoard Secretary · born 1973
- Ms. Suqing WangDeputy General Manager · born 1982
- Lu DongAccounting Supervisor